Prokidney reports business updates and first quarter 2024 financial results

Winston-salem, n.c., may 10, 2024 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney” or the “company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today reported business updates and financial results for the first quarter ended march 31, 2024.
prok Ratings Summary
prok Quant Ranking